Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,356,171
Closed -$138M 62
2025
Q3
$138M Sell
9,356,171
-143,829
-2% -$1.47M 3.84% 10
2025
Q2
$93.3M Buy
9,500,000
+183,667
+2% +$1.52M 2.99% 12
2025
Q1
$67.7M Buy
9,316,333
+2,838,084
+44% +$24.8M 2.19% 15
2024
Q4
$50.7M Buy
6,478,249
+3,711,737
+134% +$30.6M 1.89% 15
2024
Q3
$20.5M Buy
2,766,512
+472,501
+21% +$3.97M 0.65% 42
2024
Q2
$18.4M Buy
+2,294,011
New +$20.5M 0.55% 44
2023
Q4
Sell
-91,078
Closed -$1.41M 67
2023
Q3
$1.41M Sell
91,078
-412,022
-82% -$6.92M 0.05% 62
2023
Q2
$9.53M Sell
503,100
-1,296,900
-72% -$22.8M 0.44% 43
2023
Q1
$27.4M Sell
1,800,000
-2,050,000
-53% -$26.7M 1.13% 29
2022
Q4
$49M Buy
3,850,000
+1,214,000
+46% +$10.9M 2.06% 19
2022
Q3
$15.3M Buy
+2,636,000
New +$11.6M 0.7% 47

Other funds holding ETNB

Deep Track Capital's ETNB Position: Q4 2025 in Review

Deep Track Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 9,356,171 shares — an estimated $138M sold.

Deep Track Capital first reported a position in ETNB in Q3 2022 and held it in 11 quarters. The position peaked at $138M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Deep Track Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Deep Track Capital sold 9,356,171 89bio shares in Q4 2025, an estimated $138M.
  • Deep Track Capital first reported a position in 89bio in Q3 2022 and held it in 11 quarters.
  • Deep Track Capital's 89bio position peaked at $138M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.